Zhongnan Medical Journal Press

Home Results

A total of 106 result was found. Results that relate to Therapy

Research progress of LRPPRC in non-small cell lung cancer

Published on New Medicine 2025,35(10):1228-1234.
5349 times 898 times

LE Sihong ZHANG Qin FANG Weidan KUANG Peng ZHANG Ling

Non-small cell lung cancer LRPPRC Drug resistance Regulation mechanisms Immunotherapy
Details
Research advances in adverse drug reactions and their management in targeted therapy for driver gene-positive advanced non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1320-1329.
4643 times 812 times

FAN Jiameng PAN Lei

Non-small cell lung cancer Target therapy Adverse drug reactions Symptom management Biomarker
Details
Application and research progress of nanomaterials in ischemic stroke therapy

Published on New Medicine 2025,35(11):1355-1360.
4992 times 788 times

LI Zhuoyuan PENG Zheng ZHU Xiaolong LI Wei HANG Chunhua

Ischemic stroke Nanomaterials Targeted therapy
Details
Retrospective analysis of immune checkpoint inhibitor-induced colitis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1390-1398.
3190 times 641 times

SONG Jialin WU Lei WANG Yiting

Immune checkpoint inhibitors Drug-induced colitis Immunotherapy toxicity Risk factors Retrospective analysis
Details
Progress of oncolytic virus therapy in urological cancers

Published on New Medicine 2025,35(12):1464-1470.
7065 times 833 times

ZHAO Heng DU Ling WEI Fang WANG Mengqin SHOU Zhanyi FENG Shengyi WANG Lei

Oncolytic virus therapy Oncolytic effect Immunotherapy Urological cancers Prostate cancer Bladder cancer Kidney cancer
Details
Adverse drug event signal mining of ezetimibe monotherapy and compound preparations based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2026,35(2):156-163.
2979 times 688 times

HUANG Yan YU Yang

Ezetimibe Single tablet compound preparation containing ezetimibe Combination therapy Adverse drug event Signal mining Pharmacovigilance
Details
Efficacy and safety of SOX chemotherapy combined with Sintilimab immunotherapy in treatment of patients with advanced gastric cancer

Published on New Medicine 2026,36(1):15-21.
3963 times 667 times

ZHAO Wan YAN Jing GUO Yaping FU Qinghua LUO Yan ZHANG Xiaojuan CHEN Yang YANG Yi TANG Xinyu

Gastric cancer Sintilimab SOX regimen Chemotherapy response Prognosis
Details
Meta-integration of qualitative studies on the inner experience and nursing needs of breast cancer patients during radiotherapy and chemotherapy

Published on New Medicine 2026,36(1):88-96.
5100 times 660 times

ZHANG Xin ZHU Baoling LIU Min HE Jingjing

Breast cancer Radiotherapy and chemotherapy Inner experience Nursing needs Qualitative research Meta-integration
Details
A case report of vascular stent implantation for the treatment of hepatic venous outflow obstruction after liver transplantation and literature review

Published on New Medicine 2026,36(1):110-115.
3824 times 682 times

NING Yuxiang ZHOU Shujun GAO Zhuo WANG Yanfeng

Liver transplantation Hepatic venous outflow obstruction Interventional therapy
Details
Research progress on granulosa cell apoptosis in premature ovarian failure

Published on New Medicine 2026,36(2):224-230.
2749 times 527 times

ZHOU Min MAN Yicun LUO Siqi WANG Qing XIE Huixia LYU Qun

Premature ovarian failure Granulosa cell Apoptosis Molecular mechanisms Therapy
Details
Mechanism of the medicine pair of Sanhe Decoction in treatment of chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia with "homotherapy for heteropathy" based on network pharmacology and molecular docking

Published on Journal of Mathematical Medicine 2026,39(3):179-190.
1777 times 506 times

LI Shenglong JING Shuaishuai LI Hui ZHANG Qingwei GONG Meisheng LIANG Yonglin ZHOU Jiuyun ZHAO Yongqiang

Chronic prostatitis Chronic pelvic pain syndrome Benign prostatic hy-perplasia Sanhe Decoction Homotherapy for heteropathy Network pharmacology Molecular docking
Details
Integrating network pharmacology and molecular docking to elucidate the therapeutic mechanisms of Foeniculum vulgare against hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2026,30(3):361-370.
2322 times 419 times

DENG Xiaying ZHAO Xiangxuan

Foeniculum vulgare Network pharmacology Network targets Hepatocellular carcinoma Mechanism of action Molecular docking Targeted therapy Natural products
Details
Recent advances of non-viral vectors in DNA drug delivery field

Published on Frontiers in Pharmaceutical Sciences 2026,30(3):520-529.
2021 times 357 times

LIU Hanxiao YANG Xuehua LIU Zhengping MAO Kaifan XUE Song LI Dawei TANG Xuan

Non-viral vectors DNA drugs Delivery systems Targeted delivery Nanocarriers Biocompatibility Gene therapy Clinical translation
Details
The impact of postoperative transcatheter arterial infusion and systemic adjuvant therapy on prognosis in patients with R1 resection for hilar cholangiocarcinoma

Published on New Medicine 2026,36(4):385-392.
726 times 399 times

GENG Qin QIAN Chunxing LI Guowang KANG Qiang KE Yang LI Jing YANG Chen LI Yuehua

Hilar cholangiocarcinoma R1 resection Postoperative adjuvant therapy Transcatheter arterial infusion Overall survival Progression-free survival
Details
Research progress on therapeutic strategies and mechanisms of action of traditional Chinese medicines with “medicine-food homology” in the prevention and treatment of chemo-therapy-induced myelosuppression

Published on Frontiers in Pharmaceutical Sciences 2026,30(4):679-691.
1017 times 203 times

CHEN Weishi LI Jing LI Jing HAN Tao

Chemotherapy-induced myelosuppression Medicine-food homology Etiology and pathogenesis Treatment strategies Characteristics of traditional Chinese medicine Active ingredients Mechanism of action Medullary hematopoiesis
Details